In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...

WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised guidance on ...

Tuberculosis (TB) remains the leading cause of death among people living with HIV. Although HIV-1 and Mycobacterium tuberculosis (Mtb) coinfection remains a major public health concern, this problem ...

Community health worker Marc Ilboudo uses a mobile application during a consultation with a child in Pousghin, Burkina Faso. The heads of state and government from nearly 200 countries gathering this ...

Harriet Mayanja-Kizza is based at the Uganda CWRU Research Collaboration (UCRC) - a Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) Partner Site. She receives funding from NIH, ...

The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...

Nov. 29, 2023 –The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths ...

A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), according to new research. A therapy showing promise to help control tuberculosis ...

New research found that people living with HIV that have had pulmonary tuberculosis had broader and more potent HIV antibody responses and differences in HIV sequences predicted to be antibody ...

SPECIAL FEATURE | OWEN NYAKA | Titus Virinyu was diagnosed HIV+, and health experts recommended him to take anti-retrovirals ...